Burnet Pharmaceuticals Pvt Ltd, a active private limited company, was established on 30 September 1982 in Kolkata, West Bengal, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U34232WB1982PTC035307. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹4.52 Cr.
It upholds a compliant status. Employing 131 professional, Its leadership includes Om Prakash Singh (Additional Director), Ram Rekha Tewari (Managing Director), Shiv Sagar Tewari (Director). Past directors included Lalita Tewari, Satyawati Tewari, Ashok Tewary. It holds ₹17.75 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 28/5 C.N. Roy Road, Kolkata, West Bengal, 700039.
U34232WB1982PTC035307
035307
30 September 1982
₹6.00 Cr
₹4.52 Cr
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Burnet Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Om Prakash Singh | Additional Director | 01 Oct 2024 | Current |
| Ram Rekha Tewari | Managing Director | 30 Sep 1982 | Current |
| Shiv Sagar Tewari | Director | 01 Jan 1983 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jun 2018 | Past |
| Pramod Abcsdd | Director | 01 Jun 2018 | Past |
| Pramod Abcsdd | Director | 09 May 2007 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Burnet Pharmaceuticals Pvt Ltd, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.48% decrease. The company also saw a substantial improvement in profitability, with a 69.6% increase in profit. The company's net worth Soared by an impressive increase of 38.94%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Burnet Pharmaceuticals had a public holding of 30.30%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹177,450,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jun 2024 | Others | ₹5.76 Cr | Open |
| 28 Jul 2023 | Axis Bank Limited | ₹4.35 Cr | Open |
| 28 Dec 2021 | Axis Bank Limited | ₹3.00 M | Open |
| 20 Feb 2021 | Axis Bank Limited | ₹3.20 M | Open |
| 18 Feb 2004 | United Bank Of India | ₹3.48 Cr | Open |
Explore comprehensive loan charge details -
Burnet Pharmaceuticals has a workforce of 131 employees as of Sep 16, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Burnet Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Burnet Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Om Prakash Singh was appointed as a Additional Director was appointed as a Additional Director on 01 Oct 2024 & has been associated with this company since 1 year 2 months . was completed.
Burnet Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
A charge with Others amounted to Rs. 5.76 Cr with Charge ID 100942027 was registered on 24 Jun 2024. was recorded as a recent event.
Burnet Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was recorded as a recent event.
Progress on A charge with Axis Bank Limited of Rs. 4.35 Cr registered on 28 Jul 2023 with Charge ID 100784719 was modified on 29 Dec 2023. was documented.
Progress on A charge with Axis Bank Limited of Rs. 0.32 Cr registered on 20 Feb 2021 with Charge ID 100446366 was modified on 29 Aug 2023. was documented.
The CIN of Burnet Pharmaceuticals Pvt Ltd is U34232WB1982PTC035307.
Burnet Pharmaceuticals Pvt Ltd is headquartered at 28/5 C.N. Roy Road, Kolkata, West Bengal, 700039.
Burnet Pharmaceuticals Pvt Ltd was incorporated on 30 September 1982.
The current directors of Burnet Pharmaceuticals Pvt Ltd are
The primary industry of Burnet Pharmaceuticals Pvt Ltd is Manufacturing.
Burnet Pharmaceuticals Pvt Ltd is unlisted.
The authorized capital of Burnet Pharmaceuticals Pvt Ltd is ₹6.00 Cr, and the paid-up capital is ₹4.52 Cr.
The compliance status of Burnet Pharmaceuticals Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX